The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Glucocorticoid-Remediable Aldosteronism (GRA / FH-I)

Autosomal-dominant secondary hypertension from a chimeric CYP11B1/CYP11B2 gene placing aldosterone under ACTH control.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Endokrinoloji department. Book Appointment →

What is Glucocorticoid-Remediable Aldosteronism (GRA / FH-I)?

Glucocorticoid-remediable aldosteronism (GRA), also called familial hyperaldosteronism type I (FH-I), is a rare autosomal-dominant cause of secondary hypertension.

An unequal crossing-over creates a chimeric CYP11B1/CYP11B2 gene fusion that places aldosterone synthase under control of the ACTH-responsive 11-beta-hydroxylase promoter; aldosterone secretion is therefore driven by ACTH and suppressible by exogenous glucocorticoid.

Patients present with early-onset hypertension, variable hypokalemia, family history of stroke or aneurysm, and elevated 18-hydroxy-cortisol and 18-oxo-cortisol. Diagnosis is genetic; treatment uses low-dose dexamethasone or mineralocorticoid antagonists.

Symptoms

Early-onset hypertension (often before age 20)
Hypokalemia (variable, sometimes absent)
Headache, fatigue from hypertension
Muscle weakness with low potassium
Family history of intracranial aneurysms
Family history of hemorrhagic stroke
Resistant hypertension despite multiple drugs

Risk Factors

Family history of GRA or unexplained early hypertension
Affected first-degree relative
Chimeric CYP11B1/CYP11B2 gene mutation
Suppressed renin with high aldosterone-renin ratio
History of intracranial aneurysm in family
Hemorrhagic stroke at young age in family

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Early-onset or resistant hypertension
  • Hypertension with hypokalemia
  • Strong family history of hypertension or stroke
  • Suppressed renin with elevated aldosterone-renin ratio
  • Genetic counseling for affected family
  • Pregnancy planning with GRA
  • Brain imaging for aneurysm screening

Treatment Methods

01
Low-dose dexamethasone (0.125-0.25 mg/d) or prednisone
02
Mineralocorticoid receptor antagonist (spironolactone, eplerenone)
03
Add-on antihypertensives (ACEi/ARB, calcium-channel blockers)
04
Genetic confirmation and family screening
05
Brain MRA for aneurysm screening (recommended)
06
Close blood-pressure and potassium monitoring
07
Lifestyle: low-sodium diet, exercise

Which Department to Visit?

You can visit our Endokrinoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Endokrinoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.